Phase 1 study of PTK787/ZK 222584, a small molecule tyrosine kinase receptor inhibitor, for the treatment of acute myeloid leukemia and myelodysplastic syndrome

Gail J. Roboz,Francis J. Giles,Alan F. List,Jorge E. Cortes,Rebecca F. Carlin,M. Kowalski,S. Bilic,Eric Masson,M. Rosamilia,Michael W. Schuster,Dirk Laurent,Eric J. Feldman

Phase 1 study of PTK787/ZK 222584, a small molecule tyrosine kinase receptor inhibitor, for the treatment of acute myeloid leukemia and myelodysplastic syndrome

2006

Gail J. Roboz
Francis J. Giles
Alan F. List
Jorge E. Cortes
Rebecca F. Carlin
M. Kowalski
S. Bilic
Eric Masson
M. Rosamilia
Michael W. Schuster
Dirk Laurent
Eric J. Feldman

Phase 1 study of PTK787/ZK 222584, a small molecule tyrosine kinase receptor inhibitor, for the treatment of acute myeloid leukemia and myelodysplastic syndrome

Keywords:

Cancer research
Small molecule
Hematology
Receptor tyrosine kinase
Myeloid leukemia
VEGF receptors
Tyrosine-kinase inhibitor
Biology
Internal medicine
Tolerability
Pharmacology
Vascular endothelial growth factor
Tyrosine kinase
Endocrinology
Medicine
Chemotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations